{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:54:27Z","timestamp":1784159667211,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00415-025-13516-z","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:14:44Z","timestamp":1763565284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients"],"prefix":"10.1007","volume":"272","author":[{"given":"Alex","family":"Vicino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lauletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Barbaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Torchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Saccani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Faedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Iannibelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele Giovanni","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Zoppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Maria","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Colacicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Grandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie Marroun","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Carda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Th\u00e9audin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Ravaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Verriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Vattemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bortolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Ada","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Carlo","family":"Previtali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-5173","authenticated-orcid":false,"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"13516_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nmd.2024.03.001","volume":"37","author":"JB Lilleker","year":"2024","unstructured":"Lilleker JB, Naddaf E, Saris CGJ, Schmidt J, de Visser M, Weihl CC, Alexanderson H, Alfano L, Allenbach Y, Badrising U, Benveniste O, Bhai S, De Bleecker J, Breeveld MC, Chinoy H, Diederichsen L, Dimachkie M, Greenberg S, Johari M, Lilleker J, Lindgren U, Lloyd T, Machado P, Mozaffar T, Mischke R, Needham M, Nishino I, Oldfors A, Saris C, Stenzel W, Tasca G, Weihl C (2024) 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318 June 2023, Hoofddorp, The Netherlands. Neuromuscul Disord 37:36\u201351. https:\/\/doi.org\/10.1016\/j.nmd.2024.03.001","journal-title":"Neuromuscul Disord"},{"key":"13516_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","volume":"129","author":"O Benveniste","year":"2015","unstructured":"Benveniste O, Stenzel W, Hilton-Jones D et al (2015) Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol 129:611\u2013624. https:\/\/doi.org\/10.1007\/s00401-015-1384-5","journal-title":"Acta Neuropathol"},{"key":"13516_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201103","author":"F Kleefeld","year":"2022","unstructured":"Kleefeld F, Uruha A, Sch\u00e4nzer A et al (2022) Morphologic and molecular patterns of polymyositis with mitochondrial pathology and inclusion body myositis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000201103","journal-title":"Neurology"},{"key":"13516_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jnen\/nlab101","volume":"80","author":"M Winkler","year":"2021","unstructured":"Winkler M, Von Landenberg C, Kappes-Horn K et al (2021) Diagnosis and clinical development of sporadic inclusion body myositis and polymyositis with mitochondrial pathology: a single-center retrospective analysis. J Neuropathol Exp Neurol 80:1060\u20131067. https:\/\/doi.org\/10.1093\/jnen\/nlab101","journal-title":"J Neuropathol Exp Neurol"},{"issue":"21","key":"13516_CR5","doi-asserted-by":"publisher","first-page":"e2653","DOI":"10.1212\/WNL.0000000000012004","volume":"96","author":"S Shelly","year":"2021","unstructured":"Shelly S, Mielke MM, Mandrekar J, Milone M, Ernste FC, Naddaf E, Liewluck T (2021) Epidemiology and natural history of inclusion body myositis: a 40-year population-based study. Neurology 96(21):e2653\u2013e2661. https:\/\/doi.org\/10.1212\/WNL.0000000000012004","journal-title":"Neurology"},{"key":"13516_CR6","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/zvffa0","author":"UA Badrising","year":"2025","unstructured":"Badrising UA, Henderson R, Reddel S et al (2025) Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/zvffa0","journal-title":"Clin Exp Rheumatol"},{"key":"13516_CR7","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S2665-9913(20)30280-0","volume":"3","author":"O Benveniste","year":"2021","unstructured":"Benveniste O, Hogrel J-Y, Belin L et al (2021) Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. Lancet Rheumatol 3:e40\u2013e48. https:\/\/doi.org\/10.1016\/S2665-9913(20)30280-0","journal-title":"Lancet Rheumatol"},{"key":"13516_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/mus.20958","volume":"37","author":"CE Jackson","year":"2008","unstructured":"Jackson CE, Barohn RJ, Gronseth G et al (2008) Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve 37:473\u2013476. https:\/\/doi.org\/10.1002\/mus.20958","journal-title":"Muscle Nerve"},{"key":"13516_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S1474-4422(23)00275-2","volume":"22","author":"PM Machado","year":"2023","unstructured":"Machado PM, McDermott MP, Blaettler T et al (2023) Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 22:900\u2013911. https:\/\/doi.org\/10.1016\/S1474-4422(23)00275-2","journal-title":"Lancet Neurol"},{"key":"13516_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-333617","author":"S Salam","year":"2024","unstructured":"Salam S, Symonds T, Doll H et al (2024) Measurement properties of the inclusion body myositis functional rating scale. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2024-333617","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13516_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.nmd.2020.08.358","volume":"30","author":"AY Lin","year":"2020","unstructured":"Lin AY, Siener CS, Faino AV et al (2020) Optimizing hand-function patient outcome measures for inclusion body myositis. Neuromuscul Disord 30:807\u2013814. https:\/\/doi.org\/10.1016\/j.nmd.2020.08.358","journal-title":"Neuromuscul Disord"},{"key":"13516_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mus.26859","volume":"62","author":"AGS Oldroyd","year":"2020","unstructured":"Oldroyd AGS, Lilleker JB, Williams J et al (2020) Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups. Muscle Nerve 62:76\u201382. https:\/\/doi.org\/10.1002\/mus.26859","journal-title":"Muscle Nerve"},{"key":"13516_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"MR Rose","year":"2013","unstructured":"Rose MR (2013) 188th ENMC international workshop: inclusion body myositis, 2\u20134 December 2011, Naarden, The Netherlands. Neuromuscul Disord 23:1044\u20131055. https:\/\/doi.org\/10.1016\/j.nmd.2013.08.007","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"13516_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200168","volume":"13","author":"T Symonds","year":"2023","unstructured":"Symonds T, Randall J, Lloyd-Price L, Hudgens S, Dimachkie MM, Guldberg C, Machado PM (2023) Study to assess content validity and interrater and intrarater reliability of the inclusion body myositis functional rating scale. Neurol Clin Pract 13(4):e200168. https:\/\/doi.org\/10.1212\/CPJ.0000000000200168","journal-title":"Neurol Clin Pract"},{"key":"13516_CR15","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/jnnp-2020-325141","volume":"92","author":"G Sangha","year":"2021","unstructured":"Sangha G, Yao B, Lunn D et al (2021) Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis. J Neurol Neurosurg Psychiatry 92:854\u2013862. https:\/\/doi.org\/10.1136\/jnnp-2020-325141","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13516_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nmd.2013.02.010","volume":"23","author":"A Cortese","year":"2013","unstructured":"Cortese A, Machado P, Morrow J et al (2013) Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials. Neuromuscul Disord 23:404\u2013412. https:\/\/doi.org\/10.1016\/j.nmd.2013.02.010","journal-title":"Neuromuscul Disord"},{"key":"13516_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/mus.26521","volume":"60","author":"G Ramdharry","year":"2019","unstructured":"Ramdharry G, Morrow J, Hudgens S et al (2019) Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis. Muscle Nerve 60:161\u2013168. https:\/\/doi.org\/10.1002\/mus.26521","journal-title":"Muscle Nerve"},{"key":"13516_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/cells10051146","volume":"10","author":"M Lucchini","year":"2021","unstructured":"Lucchini M, Maggi L, Pegoraro E et al (2021) Anti-cN1A antibodies are associated with more severe dysphagia in sporadic inclusion body myositis. Cells 10:1146. https:\/\/doi.org\/10.3390\/cells10051146","journal-title":"Cells"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13516-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13516-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13516-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:29:43Z","timestamp":1765812583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13516-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["13516"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13516-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LM has received honoraria for speaking, advisory boards, and compensation for congress participations from Sanofi, Roche, Biogen, Amicus Therapeutics, Alexion, Argenx, UCB, Johnson & Johnson, and Lupin, outside the submitted work. CHUV received for MT honoraria for speaking, advisory boards, and compensation for congress participations from Sanofi, Roche, Biogen, Alexion, Argenx, UCB, Johnson & Johnson, Alnylam, AstraZeneca, and Takeda, outside the submitted work. ES has received honoraria for speaking, advisory boards, and compensation for congress participation from Roche, Biogen, Alexion, Argenx, and UCB, not related to the submitted work. MC has received honoraria for speaking, advisory boards, and compensation for congress participation from Roche and Biogen. EMC has received honoraria for speaking, advisory boards, and compensation for congress participation from Roche and Biogen, not related to the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted according to the Helsinki Declaration and its protocol was approved by the regional ethics committee \u201cLombardia 4\u201d under the registered study number CET 17\/24. Aggregated anonymized data were analyzed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"775"}}